Clinical and pathologic predictors of survival in patients with thymoma

Annals of Surgery

Volumn 230, Issue 4, 1999, Pages 562-574

  Wilkins, Kirsten Bass ^a   Sheikh, Emran ^a   Green, Rennae ^a   Patel, Mayur ^a   George, Simeon ^a   Takano, Manabu ^a   Diener West, Marie ^a   Welsh, James ^a   Howard, Steven ^a   Askin, Frederic ^a   Bulkley, Gregory B ^a,b  

^a DEPARTMENT OF PATHOLOGY   (United States)

^b JOHNS HOPKINS HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADOLESCENT; ADULT; AGED; CANCER ADJUVANT THERAPY; CANCER CLASSIFICATION; CANCER RADIOTHERAPY; CANCER STAGING; CANCER SURGERY; CANCER SURVIVAL; CHILD; CONFERENCE PAPER; FEMALE; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; MALE; MYASTHENIA GRAVIS; PRIORITY JOURNAL; RISK FACTOR; SECOND CANCER; SURGICAL MORTALITY; SURGICAL TECHNIQUE; THYMOMA;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; CHILD; FEMALE; HUMANS; MALE; MIDDLE AGED; NEOPLASM STAGING; PREDICTIVE VALUE OF TESTS; PREOPERATIVE CARE; RETROSPECTIVE STUDIES; SURVIVAL RATE; THYMOMA; THYMUS NEOPLASMS;

EID: 0033498340     PISSN: 00034932     EISSN: None     Source Type: Journal    
DOI: 10.1097/00000658-199910000-00012     Document Type: Conference Paper

References (40)

1. Morgenthaler TI, Brown LR, Colby TV, et al. Thymoma. Mayo Clin Proc 1993; 68:1110-1123.
2. Rosai J, Levine GD. Tumors of the thymus. Washington DC: Armed Forces Institute of Pathology; 1976.
3. Soudajian JV, Enriquez P, Silverstein MN, Pepin J-M. The spectrum of diseases associated with thymoma. Coincidence or syndrome? Arch Intern Med 1974; 134:374-379.
4. Bulkley GB, Bass KN, Stephenson GR, et al. Extended cervicomediastinal thymectomy in the integrated management of myasthenia gravis. Ann Surg 1997; 226:324-335.
5. Verley JM, Hollmann KH. Thymoma. A comparative study of clinical stages, histologic features, and survival in 200 cases. Cancer 1985; 55:1074-1086.
6. McCart JA, Gaspar L, Inculet R, Casson AG. Predictors of survival following surgical resection of thymoma. J Surg Oncol 1993; 54:233-238.
7. Masaoka A, Monden Y, Nakahara K, Tanioka T. Follow-up study of thymomas with special reference to their clinical stages. Cancer 1981; 48:2485-2492.
8. Lewis JE, Wick MR, Scheithauer BW, et al. Thymoma. A clinicopathologic review. Cancer 1987; 60:2727-2743.
9. Blumberg D, Port JL, Weksler B, et al. Thymoma: a multivariate analysis of factors predicting survival. Ann Thorac Surg 1995; 60: 908-914.
10. Quintanilla-Martinez L, Wilkins EW Jr, Choi N, et al. Thymoma. Histologic subclassification is an independent prognostic factor. Cancer 1994; 74:606-617.
11. Wilkins EW Jr, Grillo HC, Scannell JG, et al. Role of staging in prognosis and management of thymoma. Ann Thorac Surg 1991; 51:888-892.
12. Batata MA, Martini N, Huvos AG, et al. Thymomas: clinicopathologic features, therapy, and prognosis. Cancer 1974; 34:389-396.
13. Maggi G, Giaccone G, Donadio M, et al. Thymomas. A review of 169 cases, with particular reference to results of surgical treatment. Cancer 1986; 58:765-776.
14. Pescarmona E, Rendina EA, Venuta F, et al. Analysis of prognostic factors and clinicopathological staging of thymoma. Ann Thorac Surg 1990; 50:534-538.
15. Schneider PM, Fellbaum C, Fink U, et al. Prognostic importance of histomorphologic subclassification for epithelial thymic tumors. Ann Surg Oncol 1997; 4:46-56.
16. Levine GD, Rosai J. Thymic hyperplasia and neoplasia: a review of current concepts. Hum Pathol 1978; 9:495-515.
17. Salyer WR, Eggleston JC. Thymoma. A clinical and pathological study of 65 cases. Cancer 1976; 37:229-249.
18. Marino M, Müller-Hermelink HK. Thymoma and thymic carcinoma. Relation of thymoma epithelial cells to the cortical and medullary differentiation of thymus. Virchows Arch (Pathol Anat) 1985; 407: 119-149.
19. Shimosato Y, Mukai K. Tumors of the Mediastinum. Washington DC: Armed Forces Institute of Pathology; 1997.
20. Müller-Hermelink HK, Marino M, Palestro G, et al. Immunohistological evidences of cortical and medullary differentiation in thymoma. Virchows Arch A Pathol Anat Histopathol 1985; 408:143-161.
21. Kornstein MJ, Curran WJ Jr, Turrisi AT, III, Brooks JJ. Cortical versus medullary thymomas: a useful morphologic distinction? Hum Pathol 1988; 19:1335-1339.
22. Müller-Hermelink HK, Marino M, Palestro G. Pathology of thymic epithelial tumors. In: Müller-Hermelink HK, ed. The human thymus. Histophysiology and pathology. Berlin: Springer-Verlag; 1986:208-268.
23. Kuo T-T, Lo S-K. Thymoma: a study of the pathologic classification of 71 cases with evaluation of the Müller-Hermelink system. Hum Pathol 1993; 24:766-771.
24. Quintanilla-Martinez L, Wilkins EW Jr, Ferry JA, Harris NL. Thymoma - morphologic subclassification correlates with invasiveness and immunohistologic features: a study of 122 cases. Hum Pathol 1993; 24:958-969.
25. Pan C-C, Wu H-P, Yang C-F, et al. The clinicopathological correlation of epithelial subtyping in thymoma: a study of 112 consecutive cases. Hum Pathol 1994; 25:893-899.
26. Ho FCS, Fu KH, Lam SY, et al. Evaluation of a histogenetic classification for thymic epithelial tumours. Histopathology 1994; 25:21-29.
27. Ricci C, Rendina EA, Pescarmona EO, et al. Correlations between histological type, clinical behaviour, and prognosis in thymoma. Thorax 1989; 44:455-460.
28. Kaplan EL, Meier P. Nonparametric estimation from incomplete observations. J Am Stat Assoc 1958; 53:457-481.
29. Peto R, Peto J. Asymptotically efficient rank invariant procedures. J R Stat Soc A 1972; 135(pt 2):1:85-206.
30. Cox DR. Regression models and life-tables. J R Stat Soc B 1972; 134(pt 2):1:87-220.
31. Egea AM, Albasini JLA, Paricio PP, et al. Prognostic factors of thymomas. Eur J Surg Oncol 1995; 21:482-485.
32. Bergh NP, Gatzinsky P, Larsson S, et al. Tumors of the thymus and thymic region: I. Clinicopathological studies on thymomas. Ann Thorac Surg 1978; 25:91-98.
33. Monden Y, Nakahara K, Iioka S, et al. Recurrence of thymoma: Clinicopathological features, therapy, and prognosis. Ann Thorac Surg 1985; 39:165-169.
34. Ciernik IF, Meier U, Lutolf UM. Prognostic factors and outcome of incompletely resected invasive thymoma following radiation therapy. J Clin Oncol 1994; 12:1484-1490.
35. Wilkins EW Jr, Edmunds LH, Castleman B. Cases of thymoma at the Massachusetts General Hospital. J Thorac Cardiovasc Surg 1966; 52:322-330.
36. Shamji F, Pearson FG, Todd TRJ, et al. Results of surgical treatment for thymoma. J Thorac Cardiovasc Surg 1984; 87:43-47.
37. Maggi G, Casadio C, Cavallo A, et al. Thymoma: results of 241 operated cases. Ann Thorac Surg 1991; 51:152-156.
38. Tandan R, Taylor R, DiCostanzo DP, et al. Metastasizing thymoma and myasthenia gravis. Favorable response to glucocorticoids after failed chemotherapy and radiation therapy. Cancer 1990; 65:1286-1290.
39. Hu E, Levine J. Chemotherapy of malignant thymoma. Case report and review of the literature. Cancer 1986; 57:1101-1104.
40. Pescarmona E, Rendina EA, Venuta F, et al. The prognostic implication of thymoma histologic subtyping. A study of 80 consecutive cases. Am J Clin Pathol 1990; 93:190-195.